With ID NOW COVID-19 2.0, you can now choose to test for COVID-19 only, or COVID-19 and influenza A & B with the same patient swab.
The ID NOWTM COVID-19 2.0 assay delivers molecular results in just minutes, giving you real-time access to the information you need to make actionable decisions during the first patient visit.
Product may not be available in all countries.
With ID NOW COVID-19 2.0, you now have the power to choose to test for COVID-19 only or COVID-19 plus influenza A & B with the same patient swab.
The ID NOW COVID-19 2.0 assay is a nucleic acid amplification test (NAAT) that isothermally uses nicking enzyme amplification reaction (NEAR) technology. Thus, the ID NOW COVID-19 2.0 assay provides molecular results in a fraction of the time needed by traditional molecular lab tests.
With positive results in as few as 6 minutes and negative results in 12 minutes or less, ID NOW COVID-19 2.0 provides real-time diagnostics where and when you need them — in near-patient settings at the point of care.
The ID NOW platform is designed with intuitive operations that guide you at every step. The assay kit does not require refrigeration and contains all the components needed so you can test on-demand, right out of the box.
Plus, the ID NOW platform easily integrates into existing patient diagnostic workflows and readily connects with hospital, laboratory, or patient information systems.
PLEASE NOTE: The ID NOW COVID-19 2.0 assay will require a software upgrade to V7.0.0.20. Customers should have received software upgrade information in August 2022.
| ID NOW™ System |
Code |
|---|---|
| ID NOW™ Instrument |
NAT-000 (OUS) |
| ID NOW™ COVID-19 2.0 24 Test Kit | 193-000 |
| ID NOW™ COVID-19 2.0 Control Kit (12 positive, 12 blank swabs) | 192-080 |
| COVID-19 Swab Transport Tube Accessory Pack 24 Count | 190-010 |
| ID NOW™ Barcode Scanner | OPR2001ZWU1-201 (Global) |
| Universal Printer | 55115 (Global) |
Based on your current location, the content on this page may not be relevant for your country.
